EUROPEAN BIOTECHNOLOGY | “We need the political willingness to put money on the table”, said Peter Beyer, Senior Advisor at the World Health Organisation at the “Novel Antimicrobials and AMR Diagnostics 2019” conference in Berlin, which attracted around 330 stakeholders from small and large pharmaceutical companies, the FDA, major global funding initiatives and financiers such as CARB-X, FIND, JPIAMR, GARDP, ENABLE or Novo’s REPAIR impact fund etc., and from applied sciences and national hubs. At the conference, it was announced that the German Federal Ministry of Education and Research was joining the CARB-X partnership, committing 39 million euros to CARB-X.